PLA2G2D Antikörper (C-Term)
Kurzübersicht für PLA2G2D Antikörper (C-Term) (ABIN954162)
Target
Alle PLA2G2D Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 112-138, C-Term
-
Spezifität
- This antibody recognizes Human PLA2G2D (C-term).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 112-138 amino acids from the C-terminal region of human PLA2G2D
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- PLA2G2D (Phospholipase A2, Group IID (PLA2G2D))
-
Andere Bezeichnung
- PLA2G2D
-
Hintergrund
- Transposase-derived protein that may have nuclease activity (Potential). Does not have transposase activity.Synonyms: GIID sPLA2, Group IID secretory phospholipase A2, PLA2IID, Phosphatidylcholine 2-acylhydrolase 2D, Phospholipase A2 group IID, SPLASH, Secretory-type PLA stroma-associated homolog, sPLA2-IID
-
Molekulargewicht
- 16546 Da
-
Gen-ID
- 26279
-
NCBI Accession
- NP_036532
-
Pathways
- Inositol Metabolic Process
Target
-